Pharma: Novartis shares dropped 9% following setbacks in three drug trials, impacting investor confidence and market performance.
Novartis shares plummeted on Tuesday following disappointing results from its del-desiran drug trial, leaving investors concerned. Stay tuned for updates on how this will impact the company's future! 📉 #Novartis #PharmaNews
What's Your Reaction?
Like
0
Dislike
0
Love
0
Funny
0
Angry
0
Sad
0
Wow
0